Prot #002-00: Randomized, Phase II Study of MK-3475 versus Chemotherapy in Patients with Advanced Melanoma

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date4/14/134/14/19

    Funding

    • Merck Sharp & Dohme Research Laboratories (Prot #002-00)